• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过口服增强小鼠疫苗引发的呼吸道黏膜和全身性新冠病毒免疫

Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral .

作者信息

Xu Jianqing, Ren Zhihong, Cao Kangli, Li Xianping, Yang Jing, Luo Xuelian, Zhu Lingyan, Wang Xiangwei, Ding Longfei, Liang Junrong, Jin Dong, Yuan Tingting, Li Lianfeng, Xu Jianguo

机构信息

Zhongshan Hospital, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

出版信息

Front Nutr. 2021 Dec 22;8:789242. doi: 10.3389/fnut.2021.789242. eCollection 2021.

DOI:10.3389/fnut.2021.789242
PMID:35004816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8733898/
Abstract

Boosting and prolonging SARS-CoV-2 vaccine-elicited immunity is paramount for containing the COVID-19 pandemic, which wanes substantially within months after vaccination. Here we demonstrate that the unique strain of probiotic GUANKE (LPG) could promote SARS-CoV-2-specific immune responses in both effective and memory phases through enhancing interferon signaling and suppressing apoptotic and inflammatory pathways. Interestingly, oral LPG administration promoted SARS-CoV-2 neutralization antibodies even 6 months after immunization. Furthermore, when LPG was given immediately after SARS-CoV-2 vaccine inoculation, specific neutralization antibodies could be boosted >8-fold in bronchoalveolar lavage (BAL) and >2-fold in sera, T-cell responses were persistent and stable for a prolonged period both in BAL and the spleen. Transcriptional analyses showed that oral application of LPG mobilized immune responses in the mucosal and systemic compartments; in particular, gut-spleen and gut-lung immune axes were observed. These results suggest that LPG could be applied in combination with SARS-CoV-2 vaccines to boost and prolong both the effective and memory immune responses in mucosal and systemic compartments, thereby improving the efficacy of SARS-CoV-2 vaccination.

摘要

增强和延长新冠病毒疫苗诱导的免疫力对于控制新冠疫情至关重要,因为疫苗接种后几个月内免疫力会大幅下降。在此,我们证明了益生菌冠科(LPG)的独特菌株可通过增强干扰素信号传导以及抑制凋亡和炎症途径,在有效阶段和记忆阶段促进新冠病毒特异性免疫反应。有趣的是,口服LPG即使在免疫6个月后仍能促进新冠病毒中和抗体的产生。此外,在接种新冠病毒疫苗后立即给予LPG,支气管肺泡灌洗(BAL)中的特异性中和抗体可增强8倍以上,血清中可增强2倍以上,BAL和脾脏中的T细胞反应在较长时间内持续且稳定。转录分析表明,口服LPG可调动黏膜和全身区室的免疫反应;特别是,观察到了肠-脾和肠-肺免疫轴。这些结果表明,LPG可与新冠病毒疫苗联合应用,以增强和延长黏膜和全身区室的有效免疫反应和记忆免疫反应,从而提高新冠病毒疫苗接种的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8733898/28a30cb1b558/fnut-08-789242-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8733898/d728b75c890e/fnut-08-789242-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8733898/7fe03c9b066e/fnut-08-789242-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8733898/28a30cb1b558/fnut-08-789242-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8733898/d728b75c890e/fnut-08-789242-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8733898/7fe03c9b066e/fnut-08-789242-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8733898/28a30cb1b558/fnut-08-789242-g0003.jpg

相似文献

1
Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral .通过口服增强小鼠疫苗引发的呼吸道黏膜和全身性新冠病毒免疫
Front Nutr. 2021 Dec 22;8:789242. doi: 10.3389/fnut.2021.789242. eCollection 2021.
2
Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.纳米递药系统包裹的亚单位疫苗经腹腔给药不仅增强了针对 SARS-CoV-2 的全身反应,还刺激了呼吸道的反应。
Viruses. 2021 Nov 2;13(11):2202. doi: 10.3390/v13112202.
3
Lactobacillus plantarum GUANKE modulate anti-viral function of dendritic cells in mice.植物乳杆菌 GUANKE 调节小鼠树突状细胞的抗病毒功能。
Int Immunopharmacol. 2024 Jun 15;134:112169. doi: 10.1016/j.intimp.2024.112169. Epub 2024 May 10.
4
Alterations in the gut microbiome and its metabolites are associated with the immune response to mucosal immunization with -displaying recombinant SARS-CoV-2 spike epitopes in mice.肠道微生物组及其代谢物的改变与在小鼠中用展示 SARS-CoV-2 刺突表位的重组蛋白进行黏膜免疫的免疫反应有关。
Front Cell Infect Microbiol. 2023 Aug 29;13:1242681. doi: 10.3389/fcimb.2023.1242681. eCollection 2023.
5
The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.细菌黏膜免疫疗法 MV130 可预防 SARS-CoV-2 感染并提高 COVID-19 疫苗的免疫原性。
Front Immunol. 2021 Nov 18;12:748103. doi: 10.3389/fimmu.2021.748103. eCollection 2021.
6
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.黏膜疫苗对恒河猴感染 SARS-CoV-2 的保护作用。
JCI Insight. 2021 Apr 28;6(10):148494. doi: 10.1172/jci.insight.148494.
7
Commentary: Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral .评论:通过口服增强小鼠疫苗诱导的呼吸道黏膜和全身性新冠病毒免疫
Front Nutr. 2022 Feb 18;9:846379. doi: 10.3389/fnut.2022.846379. eCollection 2022.
8
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
9
Strains Can Enhance Human Mucosal and Systemic Immunity and Prevent Non-steroidal Anti-inflammatory Drug Induced Reduction in T Regulatory Cells.菌株可增强人体黏膜和全身免疫力,并预防非甾体抗炎药引起的调节性T细胞减少。
Front Immunol. 2017 Aug 23;8:1000. doi: 10.3389/fimmu.2017.01000. eCollection 2017.
10
Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.使用病毒刺突蛋白DNA和蛋白质进行初免-加强免疫接种对中东呼吸综合征冠状病毒的交叉保护作用。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01176-20.

引用本文的文献

1
Modulation of oral vaccine efficacy by the gut microbiota.肠道微生物群对口服疫苗效力的调节作用。
NPJ Vaccines. 2025 Aug 1;10(1):179. doi: 10.1038/s41541-025-01240-8.
2
Safety Assessment of GUANKE Based on Whole-Genome Sequencing, Phenotypic, and Anti-Inflammatory Capacity Analysis.基于全基因组测序、表型及抗炎能力分析的冠科安全性评估
Microorganisms. 2025 Apr 10;13(4):873. doi: 10.3390/microorganisms13040873.
3
Preclinical Safety Assessment of the Oral Administration of Lactobacillus plantarum GUANKE in Animal Models.植物乳杆菌观克口服给药在动物模型中的临床前安全性评估。

本文引用的文献

1
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19.COVID-19 中的 NF-κB、炎症和细胞因子风暴三联征。
Int Immunopharmacol. 2021 Dec;101(Pt B):108255. doi: 10.1016/j.intimp.2021.108255. Epub 2021 Oct 15.
2
Autoinflammatory Diseases and Cytokine Storms-Imbalances of Innate and Adaptative Immunity.自身炎症性疾病和细胞因子风暴:固有免疫和适应性免疫失衡。
Int J Mol Sci. 2021 Oct 18;22(20):11241. doi: 10.3390/ijms222011241.
3
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。
Probiotics Antimicrob Proteins. 2025 Mar 3. doi: 10.1007/s12602-025-10498-2.
4
Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis.新冠病毒病急性后遗症中的慢性炎症对肠道微生物群产生调节作用:关于新冠病毒病后遗症与肠道菌群失调的文献综述
Mol Med. 2025 Jan 23;31(1):22. doi: 10.1186/s10020-024-00986-6.
5
Administration of GUANKE alleviates SARS-CoV-2-induced pneumonia in mice.冠科(GUANKE)的给药可减轻小鼠中由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的肺炎。
Microbiol Spectr. 2024 Oct 21;12(12):e0160324. doi: 10.1128/spectrum.01603-24.
6
Exploring the associations between gut microbiota composition and SARS-CoV-2 inactivated vaccine response in mice with type 2 diabetes mellitus.探索 2 型糖尿病小鼠肠道微生物组成与 SARS-CoV-2 灭活疫苗反应之间的关联。
mSphere. 2024 Sep 25;9(9):e0038024. doi: 10.1128/msphere.00380-24. Epub 2024 Aug 27.
7
The Immunomodulatory Effects and Applications of Probiotic Lactiplantibacillus plantarum in Vaccine Development.益生菌植物乳杆菌在疫苗开发中的免疫调节作用及其应用。
Probiotics Antimicrob Proteins. 2024 Dec;16(6):2229-2250. doi: 10.1007/s12602-024-10338-9. Epub 2024 Aug 5.
8
Deciphering the Potential of Probiotics in Vaccines.解读益生菌在疫苗中的潜力。
Vaccines (Basel). 2024 Jun 26;12(7):711. doi: 10.3390/vaccines12070711.
9
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.精准营养以重置长期新冠病毒感染中病毒诱导的人类代谢重编程和失调(HMRD)。
NPJ Sci Food. 2024 Mar 30;8(1):19. doi: 10.1038/s41538-024-00261-2.
10
Probiotic GUANKE effectively alleviates allergic rhinitis symptoms by modulating functions of various cytokines and chemokines.益生菌“观科”通过调节多种细胞因子和趋化因子的功能有效缓解过敏性鼻炎症状。
Front Nutr. 2024 Jan 15;10:1291100. doi: 10.3389/fnut.2023.1291100. eCollection 2023.
N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.
4
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
5
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.通过大规模疫苗接种建立对SARS-CoV-2感染的群体免疫面临的挑战。
Lancet. 2020 Nov 21;396(10263):1614-1616. doi: 10.1016/S0140-6736(20)32318-7. Epub 2020 Nov 4.
6
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.什么是有效的 COVID-19 疫苗?评估针对 SARS-CoV-2 的疫苗临床疗效的挑战综述。
Lancet Infect Dis. 2021 Feb;21(2):e26-e35. doi: 10.1016/S1473-3099(20)30773-8. Epub 2020 Oct 27.
7
Transcriptional regulation of memory B cell differentiation.记忆 B 细胞分化的转录调控。
Nat Rev Immunol. 2021 Apr;21(4):209-220. doi: 10.1038/s41577-020-00446-2. Epub 2020 Oct 6.
8
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.人源 IgG 中和单克隆抗体阻断 SARS-CoV-2 感染。
Cell Rep. 2020 Jul 21;32(3):107918. doi: 10.1016/j.celrep.2020.107918. Epub 2020 Jul 3.
9
The Roles of CCR7 for the Homing of Memory CD8+ T Cells into Their Survival Niches.CCR7在记忆性CD8 + T细胞归巢至其存活微环境中的作用。
Immune Netw. 2020 May 20;20(3):e20. doi: 10.4110/in.2020.20.e20. eCollection 2020 Jun.
10
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.COVID-19 中的细胞因子风暴:发病机制和治疗中使用的抗炎药物概述。
Clin Rheumatol. 2020 Jul;39(7):2085-2094. doi: 10.1007/s10067-020-05190-5. Epub 2020 May 30.